These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27966454)

  • 1. Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation.
    Sun Y; Cheng H; Wang G; Yu G; Zhang D; Wang Y; Fan W; Yang W
    Oncotarget; 2017 Jan; 8(2):3509-3518. PubMed ID: 27966454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
    Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
    Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis.
    Luan W; Zhou Z; Ni X; Xia Y; Wang J; Yan Y; Xu B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):531-542. PubMed ID: 29350287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
    Liu R; Li J; Lai Y; Liao Y; Liu R; Qiu W
    Int J Biol Macromol; 2015 Nov; 81():491-7. PubMed ID: 26275461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of long noncoding RNA MALAT1 inhibits the development of uveal melanoma via microRNA-608-mediated inhibition of HOXC4.
    Wu S; Chen H; Zuo L; Jiang H; Yan H
    Am J Physiol Cell Physiol; 2020 May; 318(5):C903-C912. PubMed ID: 31913701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
    Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
    Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
    Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW
    J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
    Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma.
    Fu Z; Luo W; Wang J; Peng T; Sun G; Shi J; Li Z; Zhang B
    Biochem Biophys Res Commun; 2017 Oct; 492(3):480-486. PubMed ID: 28834690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.
    Liu S; Song L; Zeng S; Zhang L
    Tumour Biol; 2016 Jan; 37(1):633-40. PubMed ID: 26242259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
    Chang SM; Hu WW
    J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA LINC00115 facilitates lung cancer progression through miR-607/ITGB1 pathway.
    Wu B; Xue X; Lin S; Tan X; Shen G
    Environ Toxicol; 2022 Jan; 37(1):7-16. PubMed ID: 34643030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
    Xiao H; Tang K; Liu P; Chen K; Hu J; Zeng J; Xiao W; Yu G; Yao W; Zhou H; Li H; Pan Y; Li A; Ye Z; Wang J; Xu H; Huang Q
    Oncotarget; 2015 Nov; 6(35):38005-15. PubMed ID: 26461224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis.
    Wu Q; Meng WY; Jie Y; Zhao H
    J Cell Physiol; 2018 Sep; 233(9):6750-6757. PubMed ID: 29226325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation.
    Wu C; Zhu X; Tao K; Liu W; Ruan T; Wan W; Zhang C; Zhang W
    Mol Carcinog; 2018 Oct; 57(10):1421-1431. PubMed ID: 29964337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
    Bai J; Zhang Z; Li X; Liu H
    Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
    Wang QM; Lian GY; Song Y; Huang YF; Gong Y
    Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of lncRNA MALAT1 attenuates renal interstitial fibrosis through miR-124-3p/ITGB1 axis.
    Xia W; Chen X; Zhu Z; Chen H; Li B; Wang K; Huang L; Liu Z; Chen Z
    Sci Rep; 2023 Oct; 13(1):18076. PubMed ID: 37872392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.